International Journal of Radiation Oncology * Biology * Physics
Volume 67, Issue 3 , Pages 812-822 , 1 March 2007

Brachytherapy versus prostatectomy in localized prostate cancer: Results of a French multicenter prospective medico-economic study

  • Catherine Buron, Ph.D.

      Affiliations

    • Department of Medical Information, Institut Curie, Paris, France
  • ,
  • Beatrice Le Vu, M.D.

      Affiliations

    • Department of Medical Information, Institut Curie, Paris, France
  • ,
  • Jean-Marc Cosset, M.D.

      Affiliations

    • Department of Oncology/Radiotherapy, Institut Curie, Paris, France
  • ,
  • Pascal Pommier, M.D., Ph.D.

      Affiliations

    • Department of Radiotherapy, Centre Leon Berard, Lyon, France
  • ,
  • Didier Peiffert, M.D.

      Affiliations

    • Department of Radiotherapy, Centre Alexis Vautrin, Nancy, France
  • ,
  • Martine Delannes, M.D.

      Affiliations

    • Department of Radiotherapy, Centre Claudius Regaud, Toulouse, France
  • ,
  • Thierry Flam, M.D.

      Affiliations

    • Department of Urology, Hôpital Cochin, Paris, France
  • ,
  • Stephane Guerif, M.D., Ph.D.

      Affiliations

    • Department of Radiotherapy, Centre Hospitalier Universitaire, Poitiers, France
  • ,
  • Naji Salem, M.D.

      Affiliations

    • Department of Radiotherapy, Institut Paoli-Calmettes, Marseille, France
  • ,
  • Laurent Chauveinc, M.D., Ph.D.

      Affiliations

    • Department of Radiotherapy, Clinique Hartmann, Neuilly sur Seine, France
  • ,
  • Alain Livartowski, M.D.

      Affiliations

    • Department of Medical Information, Institut Curie, Paris, France
    • Corresponding Author InformationReprint requests to: Alain Livartowski, M.D., Department of Medical Information, Institut Curie, 25 rue d’Ulm, 75005 Paris, France. Tel: (+33) 1-4432-4683; Fax: (+33) 1-5310-4039

Received 21 April 2006 ,Revised 20 September 2006 ,Accepted 4 October 2006.

References 

  1. Remontet L, Esteve J, Bouvier AM, et al. Cancer incidence and mortality in France over the period 1978–2000. Rev Epidemiol Sante Publique. 2003;51:3–30
  2. D’Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiotherapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280:1584–1586
  3. Stokes SH. Comparison of biochemical disease-free survival of patients with localized carcinoma of the prostate undergoing radical prostatectomy, transperineal ultrasound-guided radioactive seed implantation, or definitive external beam irradiation. Int J Radiat Oncol Biol Phys. 2000;47:129–136
  4. Kupelian PA, Potters L, Khuntia D, et al. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or = 72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1–T2 prostate cancer. Int J Radiat Oncol Biol Phys. 2004;58:25–33
  5. Potters L, Klein EA, Kattan MW, et al. Monotherapy for stage T1–T2 prostate cancer: Radical prostatectomy, external beam radiotherapy, or permanent seed implantation. Radiother Oncol. 2004;71:29–33
  6. Soulie M, Barre C, Beuzeboc P, et al. Prostate cancer. Prog Urol. 2004;14:927–929
  7. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–376
  8. Aaronson NK, Van Andel G EORTC Genito-Urinary Tract Cancer Group. An international field of the reliability and validity of the QLQ-C30 and a disease-specific questionnaire module (QLQ-PR25) for assessing quality of life of patients with prostate cancer. European Organization for Research and Treatment of Cancer study protocol (15011). 2002;Brussels
  9. Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16:139–144
  10. Lee WR, Hall MC, McQuellon RP, et al. A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 2001;51:614–623
  11. Eton DT, Lepore SJ, Helgeson VS. Early quality of life in patients with localized prostate carcinoma: An examination of treatment-related, demographic, and psychosocial factors. Cancer. 2001;92:1451–1459
  12. Litwin MS, McGuigan KA, Shpall AI, et al. Recovery of health related quality of life in the year after radical prostatectomy: Early experience. J Urol. 1999;161:515–519
  13. Lubeck DP, Litwin MS, Henning JM, et al. Changes in health-related quality of life in the first year after treatment for prostate cancer: Results from CaPSURE. Urology. 1999;53:180–186
  14. Brandeis JM, Litwin MS, Burnison CM, et al. Quality of life outcomes after brachytherapy for early stage prostate cancer. J Urol. 2000;163:851–857
  15. Krupski T, Petroni GR, Bissonette EA, et al. Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer. Urology. 2000;55:736–742
  16. Wei JT, Dunn RL, Sandler HM, et al. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol. 2002;20:557–566
  17. Soderdahl DW, Davis JW, Schellhammer PF, et al. Prospective longitudinal comparative study of health-related quality of life in patients undergoing invasive treatments for localized prostate cancer. J Endourol. 2005;19:318–326
  18. Miller DC, Sanda MG, Dunn RL, et al. Long-term outcomes among localized prostate cancer survivors: Health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol. 2005;23:2772–2780
  19. Downs TM, Sadetsky N, Pasta DJ, et al. Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer—data from CaPSURE. J Urol. 2003;170:1822–1827
  20. Potosky AL, Legler J, Albertsen PC, et al. Health outcomes after prostatectomy or radiotherapy for prostate cancer: Results from the Prostate Cancer Outcomes Study. J Natl Cancer Inst. 2000;92:1582–1592
  21. Talcott JA, Manola J, Clark JA, et al. Time course and predictors of symptoms after primary prostate cancer therapy. J Clin Oncol. 2003;21:3979–3986
  22. Litwin MS, Pasta DJ, Yu J, et al. Urinary function and bother after radical prostatectomy or radiation for prostate cancer: A longitudinal, multivariate quality of life analysis from the cancer of the prostate strategic urologic research endeavor. J Urol. 2000;164:1973–1977
  23. Arterbery VE, Frazier A, Dalmia P, et al. Quality of life after permanent prostate implant. Semin Surg Oncol. 1997;13:461–464
  24. Hollenbeck BK, Dunn RL, Wei JT, et al. Neoadjuvant hormonal therapy and older age are associated with adverse sexual health-related quality-of-life outcome after prostate brachytherapy. Urology. 2002;59:480–484
  25. Wagner TT, Young D, Bahnson RR. Charge and length of hospital stay analysis of radical retropubic prostatectomy and transperineal prostate brachytherapy. J Urol. 1999;161:1216–1218
  26. Ciezki JP, Klein EA, Angermeier KW, et al. Cost comparison of radical prostatectomy and transperineal brachytherapy for localized prostate cancer. Urology. 2000;55:68–72
  27. Kohan AD, Armenakas NA, Fracchia JA. The perioperative charge equivalence of interstitial brachytherapy and radical prostatectomy with 1-year followup. J Urol. 2000;163:511–514
  28. Norderhaug I, Dahl O, Hoisaeter PA, et al. Brachytherapy for prostate cancer: A systematic review of clinical and cost effectiveness. Eur Urol. 2003;44:40–46
  29. Makhlouf AA, Boyd JC, Chapman TN, et al. Perioperative costs and charges of prostate brachytherapy and prostatectomy. Urology. 2002;60:656–660
  30. Brandeis J, Pashos CL, Henning JM, et al. A nationwide charge comparison of the principal treatments for early stage prostate carcinoma. Cancer. 2000;89:1792–1799

 Supported by a grant from the French Ministry of Health STIC 2000.

 Conflict of interest: none.

PII: S0360-3016(06)03247-0

doi: 10.1016/j.ijrobp.2006.10.011

International Journal of Radiation Oncology * Biology * Physics
Volume 67, Issue 3 , Pages 812-822 , 1 March 2007